Rockwell Medical (RMTI) Cash & Current Investments (2010 - 2026)

Rockwell Medical has reported Cash & Current Investments for 17 years, with the latest figure at $23.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 37.85% year-over-year to $23.9 million; the trailing twelve-month figure through Mar 2026 stood at $23.9 million (up 37.85% YoY), and the FY2025 full-year result was $25.0 million, up 15.72% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $23.9 million, down from $25.0 million in the prior quarter.
• The five-year high for Cash & Current Investments was $30.8 million in Q2 2022, with the low at $8.6 million in Q1 2024.
• Historically, Cash & Current Investments has averaged $18.4 million across 5 years, with a median of $18.3 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments sank 78.54% — and 2025, when it soared 101.08%.
• Rockwell Medical's Cash & Current Investments stood at $21.5 million in 2022, then plunged by 49.12% to $10.9 million in 2023, then jumped by 97.55% to $21.6 million in 2024, then increased by 15.72% to $25.0 million in 2025, then fell by 4.43% to $23.9 million in 2026.
• The last three Cash & Current Investments figures came in at $23.9 million (Q1 2026), $25.0 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.